Alexandra Kropotova

Insider Reports History

Location
Byran, TX
Signature
/s/ Marc Banjak, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Alexandra Kropotova:

Company Role Class Num Shares Value Price $ Report Date Ownership
SAB Biotherapeutics, Inc. CHIEF MEDICAL OFFICER Common Stock 45,272 $95,071 $2.1 19 Sep 2025 Direct
SAB Biotherapeutics, Inc. CHIEF MEDICAL OFFICER Stock Option (right to buy) 2,400,000 26 Aug 2025 Direct
iBio, Inc. Director Stock Option (right to buy) 13,500 20 Nov 2025 Direct

Insider Reports Filed by Alexandra Kropotova

Symbol Company Period Transactions Value $ Form Type Role Filing Time
IBIO iBio, Inc. 20 Nov 2025 1 $0 4 Director 24 Nov 2025, 16:07
SABS SAB Biotherapeutics, Inc. 19 Sep 2025 1 $0 4 CHIEF MEDICAL OFFICER 22 Sep 2025, 17:00
SABS SAB Biotherapeutics, Inc. 26 Aug 2025 1 $0 4 CHIEF MEDICAL OFFICER 28 Aug 2025, 17:00
SABS SAB Biotherapeutics, Inc. 27 Mar 2025 1 $0 4 CHIEF MEDICAL OFFICER 01 Apr 2025, 16:19
SABS SAB Biotherapeutics, Inc. 18 Dec 2024 1 $0 4 CHIEF MEDICAL OFFICER 31 Dec 2024, 17:49
IBIO iBio, Inc. 21 Nov 2024 1 $0 4 Director 25 Nov 2024, 16:32
SABS SAB Biotherapeutics, Inc. 21 Feb 2024 1 $0 4 CHIEF MEDICAL OFFICER 23 Feb 2024, 17:00
SABS SAB Biotherapeutics, Inc. 14 Mar 2023 1 $0 4 Chief Medical Officer 16 Mar 2023, 16:30
SABS SAB Biotherapeutics, Inc. 13 Sep 2022 1 $0 4 Chief Medical Officer 15 Sep 2022, 17:00
SABS SAB Biotherapeutics, Inc. 06 Jun 2022 1 $0 4 Chief Medical Officer 07 Jun 2022, 20:00
SABS SAB Biotherapeutics, Inc. 06 Jun 2022 0 $0 3 Chief Medical Officer 07 Jun 2022, 19:00
IBIO iBio, Inc. 09 Dec 2021 1 $0 4 Director 13 Dec 2021, 18:08